Pfizer recalls batches of blood pressure drug Accupril

US pharmaceutical giant Pfizer is voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

The company said it was not aware of any reports of adverse events related to the recalled batches, which were distributed in the United States and Puerto Rico from December 2019 to April 2022.

Pfizer Canada also recalled all lots of three doses of Accupril last week after finding the same impurity to be above acceptable levels.

Pfizer said there was no immediate risk to patients taking this medication, in which the agent, a nitrosamine, was found.

In its statement Pfizer said:

“Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”
“Accupril is indicated for the treatment of hypertension, to lower blood pressure.  Accupril is also indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics and/or digitalis. Accupril has a safety profile that has been established over 30 years.”

It added: “To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data.”

“Although long-term ingestion of N-nitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication. Patients currently taking the products should consult with their doctor or health care provider about alternative treatment options for them.”

Follow us on twitter: @risksEmerging

From @Breakingviews: Inflation is finally killing shaky U.S. trade-war logic, @GinaChon says http://reut.rs/3R8GRe2

Chanel opted for a low-key rendition of haute couture for the French fashion house's fall-winter runway show, sending out a mix of long, full-skirted dresses and tweed ensembles with slightly relaxed fits https://reut.rs/3AANW0W

Spot #Uranium was down slightly by -16c to $50.27/lb #U3O8 today for #Nuclear fuel brokers @Numerco🪂 down -50c to $50.00/lb even for @EvoMarkets⬇️ and slid $1.13 to $49.38/lb at US 'Uranium Markets'.🛝 UxC reported their Daily Spot Price Indicator off 25c at $50.25/lb.🪂

«Sarebbe importante che il Trattato entrasse nelle trattative della #COP27. Alcuni Paesi potrebbero fare da leader nell'avanzare questa proposta: magari l’Italia?»
https://avvenire-ita.newsmemory.com/?publink=4c968b13f_1348545
#FossilfuelTreaty @wganapini @PaolaFiore @RosalbaGiugni @FedericaBosello @gruggieri

CERN’s Large Hadron Collider Resumes Research After Hiatus! #BigData #Analytics #DataScience #AI #MachineLearning #IoT #IIoT #PyTorch #Python #RStats #TensorFlow #JavaScript #ReactJS #CloudComputing #Serverless #Linux #Programming #Coding #100DaysofCode
https://geni.us/CERNWSJ

A data set of nearly eight million articles about Ukraine collected from more than 8,000 Russian websites since 2014 shows that references to Nazism were relatively flat for eight years and then spiked to unprecedented levels on Feb. 24 https://www.nytimes.com/interactive/2022/07/02/world/europe/ukraine-nazis-russia-media.html?fbclid=IwAR3Fjdl9WY9G3OjiDfFNt78O6DvyOBtk4L4sBesEkz_5znZy6ijeYos1t_Q

Load More...
SHARE: